Machine Learning Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI PRNewswire Oct 29, 2024 Investments will support new product offerings, US expansion, and development of pathology foundation models. Aignostics, a global artificial…
Machine Learning Nucleai Appoints New Head of Pathology to Support Expansion in Biopharmaceutical and Clinical… AIT News Desk Aug 3, 2022 Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, announced the appointment of…
Life Sciences Nucleai Closes $33 Million Series B Financing to Advance Spatial Biology Platform for Drug Research,… AIT News Desk Apr 4, 2022 Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its…